Know your partner
before the meeting starts
Tailored partnering briefs for early-stage biotech teams — we analyze partner decision drivers, map deal patterns, and turn them into actionable talking points.
Request Your Partner Briefs████████ Inc.
Targeted protein degradation — proprietary platform
Decision Drivers
Recent focus on multi-target discovery. Expanded 20██. Milestones exceed ¥██B.
Talking Points
Highlight proprietary E3 ligase binders and ██████ moieties.
20 meetings in 3 days —
no time to prepare thoroughly
Stretched thin
Without a dedicated BD team, CEOs and CSOs spend hours researching each counterpart on top of their core responsibilities.
Surface-level prep
A quick website scan isn't enough. Understanding a partner's deal patterns, portfolio gaps, and preferences requires deep, structured research.
Missed follow-ups
After meetings, connecting key discussion points to clinical evidence and structuring a proper follow-up often falls through the cracks.
End-to-End Partnering Intelligence
Target Discovery & Prioritization
- Analyze deal activity and in-licensing
- Prioritize targets using fit scoring
- Map technical alignment
Engagement Intelligence
- Map tailored asset narratives
- Prepare defensible talking points
- Identify stakeholder incentives
Execution & Deal Tracking
- Link discussion to evidence
- Structure clinical follow-ups
- Track partner risks & progression